TY  - JOUR
AU  - Gil-Núñez, A
AU  - Masjuan, J
AU  - Montaner, J
AU  - Castellanos, M
AU  - Segura, T
AU  - Cardona, P
AU  - Tembl, J I
AU  - Purroy, F
AU  - Arenillas, J
AU  - Palacio, E
PY  - 2020
DO  - 10.1016/j.nrl.2020.11.006
UR  - http://hdl.handle.net/10668/22445
T2  - Neurologia
AB  - Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the incidence of new vascular events, although in a substantial...
LA  - en
KW  - Cerebrovascular disease
KW  - Colesterol LDL
KW  - Dislipemia
KW  - Dyslipidemia
KW  - Enfermedad cerebrovascular
KW  - Ictus
KW  - LDL cholesterol
KW  - Prevención secundaria
KW  - Secondary prevention
KW  - Stroke
TI  - Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance.
T2  - Inhibidores de la proproteína convertasa subtilisina/kexina tipo 9 (iPCSK9) en la prevención secundaria de episodios vasculares en pacientes con ictus isquémico: Documento de consenso y aplicaciones prácticas.
TY  - research article
ER  -